For more than 70 years, research has been a part of CCO’s mandate.
CCO research produces high-quality evidence to support decision-making, and influences how care for cancer, kidney disease and other conditions are organized and delivered across Ontario.
Post-doctoral fellowship and new investigator award applications are currently being accepted. These opportunities are being offered by the KRESCENT program, in partnership with the Ontario Renal Network. The focus of the research must relate to the Ontario CKD population and should align with Ontario Renal Plan priorities.
Applications will be accepted until February 1, 2018.
Visit the KRESCENT site for more information.
CCO does not conduct clinical trials. To find clinical trials in Canada, visit: